Profile data is unavailable for this security.
About the company
Neuca SA is a Poland-based company, which operates in the healthcare market. The Company is mainly involved in the distribution of drugs to pharmacies. It also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
- Revenue in PLN (TTM)11.81bn
- Net income in PLN146.27m
- Incorporated2001
- Employees5.19k
- LocationNeuca SAul. Forteczna 35-37TORUN 87-100PolandPOL
- Phone+48 566694000
- Fax+48 566694111
- Websitehttps://www.neuca.pl/
More ▼
Mergers & acquisitions
| Acquired company | NEU:WSE since announced | Transaction value |
|---|---|---|
| Ewa SA | 14.88% | -- |
Data delayed at least 15 minutes, as of May 02 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nu Skin Enterprises, Inc. | 7.92bn | 34.55m | 2.48bn | 3.70k | 76.52 | 0.7474 | 7.75 | 0.313 | 0.1622 | 0.1622 | 38.97 | 16.61 | 1.09 | 1.95 | 32.75 | 532,197.60 | 0.4739 | 6.80 | 0.5848 | 8.90 | 68.93 | 73.45 | 0.4365 | 5.26 | 1.28 | -- | 0.3797 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| YSB Inc | 9.43bn | -1.77bn | 2.80bn | 6.31k | -- | 2.62 | -- | 0.2971 | -25.60 | -25.60 | 47.43 | 3.23 | -- | -- | -- | 2,904,308.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Uniphar PLC | 11.04bn | 193.85m | 2.95bn | 3.26k | 15.20 | 2.05 | 8.46 | 0.2668 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 29.68bn | 326.30m | 3.54bn | 4.90k | 10.90 | 0.9555 | -- | 0.1193 | 0.4457 | 0.4457 | 40.51 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Herbalife Ltd | 20.40bn | 551.55m | 3.84bn | 9.20k | 6.99 | -- | 3.79 | 0.1884 | 1.37 | 1.37 | 50.57 | -10.39 | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.98 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
| Neuca SA | 11.81bn | 146.27m | 4.06bn | 5.19k | 28.35 | 4.09 | 14.82 | 0.3439 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 12.15bn | 27.75m | 4.09bn | 6.03k | 147.45 | 2.19 | 51.38 | 0.3368 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
| DocMorris AG | 4.30bn | -521.88m | 4.98bn | 1.45k | -- | 2.24 | -- | 1.16 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
| Guangxi LiuYao Group Co Ltd | 11.80bn | 493.47m | 5.05bn | 5.58k | 9.27 | 1.19 | -- | 0.4279 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| Sigma Healthcare Ltd | 9.08bn | 11.98m | 5.62bn | 156.00 | 327.85 | 2.34 | 62.83 | 0.6184 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
Data as of May 02 2024. Currency figures normalised to Neuca SA's reporting currency: Polish New Zloty PLN
21.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FORUM TFI SAas of 28 Mar 2023 | 471.46k | 10.55% |
| Allianz Polska TFI SAas of 28 Mar 2023 | 231.16k | 5.18% |
| TFI PZU SAas of 30 Jun 2023 | 83.71k | 1.87% |
| Vienna PTE SA Vienna Insurance Groupas of 31 Dec 2021 | 57.39k | 1.29% |
| PKO TFI SAas of 31 Oct 2023 | 39.42k | 0.88% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 38.90k | 0.87% |
| Goldman Sachs Towarzystwo Funduszy Inwestycyjnych SAas of 30 Jun 2023 | 21.38k | 0.48% |
| Pekao TFI SAas of 30 Jun 2023 | 14.90k | 0.33% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 14.09k | 0.32% |
| Investors TFI SAas of 31 Dec 2022 | 9.89k | 0.22% |
More ▼
Data from 31 Dec 2021 - 28 Mar 2024Source: FactSet Research Systems Inc.
